UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly's treatment for early Alzheimer's, the ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and ...

Eli Lilly's treatment for early Alzheimer's was deemed too expensive for wide use by UK's cost-effectiveness body on ...

"Slim Aarons: Gold Coast" is organized by Shawn Waldron, the curator for Getty Images and manager of the Slim Aarons Archive ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

A counter lawsuit asking a judge to force two Waynesboro Board of Election members to certify the Nov. 5 election was filed ...

In Washington state, four agricultural workers tested presumptively positive for avian influenza after contact with infected ...

Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

Her willingness to challenge the status quo helped shape a new era in corporate responsibility, writes Marc Benioff.

The U.K. watchdog declines to endorse Eli Lilly's Alzheimer's drug donanemab, citing lack of value for the NHS and ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.